We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$3.85B
1-Year Est. Return
32.11%
This Fund
S&P 500
This Quarter
Est. Return
-13.86%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.39B
AUM Growth
+$23.5M
(+1.7%)
Cap. Flow
+$245M
Cap. Flow
% of AUM
17.64%
Top 10 Holdings %
Top 10 Hldgs %
24.95%
Holding
4,841
New
999
Increased
1,367
Reduced
1,469
Closed
908
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$123M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$48M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$45M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$25.7M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$124M |
| 2 |
iShares US Real Estate ETF
IYR
|
+$28.6M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$26.3M |
| 4 |
iShares Russell 3000 ETF
IWV
|
+$22.5M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.26% |
| 2 | Financials | 5.86% |
| 3 | Technology | 5.03% |
| 4 | Energy | 4.85% |
| 5 | Consumer Discretionary | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Adicet Bio
ACET
$74.7M
| $12K | ﹤0.01% |
12
-8
| -40% | -$10.5K |
|
2302
Ark Restaurants
ARKR
$20.2M
| $12K | ﹤0.01% |
672
+182
| +37% | +$4.04K |
|
2303
Archrock
AROC
$5.8B
| $12K | ﹤0.01% |
1,607
-2,682
| -63% | -$27.2K |
|
2304
Autohome
ATHM
$2.62B
| $12K | ﹤0.01% |
+156
| New | +$11.8K |
|
2305
AudioCodes
AUDC
$253M
| $12K | ﹤0.01% |
1,177
+683
| +138% | +$7.32K |
|
2306
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$97.7M
| $12K | ﹤0.01% |
14
-6
| -30% | -$5.55K |
|
2307
Babcock & Wilcox
BW
$1.39B
| $12K | ﹤0.01% |
3,028
+299
| +11% | +$2.66K |
|
2308
Calix
CALX
$2.39B
| $12K | ﹤0.01% |
1,240
-3,083
| -71% | -$26.8K |
|
2309
CONMED
CNMD
$1.47B
| $12K | ﹤0.01% |
+180
| New | +$12.3K |
|
2310
CenterPoint Energy
CNP
$26.8B
| $12K | ﹤0.01% |
428
-40,009
| -99% | -$1.12M |
|
2311
Cohen & Steers
CNS
$4.3B
| $12K | ﹤0.01% |
+360
| New | +$13.3K |
|
2312
Cohu
COHU
$2.5B
| $12K | ﹤0.01% |
776
+739
| +1,997% | +$14.1K |
|
2313
Cemex
CX
$16.3B
| $12K | ﹤0.01% |
2,553
+1,853
| +265% | +$9.88K |
|
2314
Eagle Bancorp Montana
EBMT
$190M
| $12K | ﹤0.01% |
722
+480
| +198% | +$8.18K |
|
|
ESPR
2315
DELISTED
Esperion Therapeutics
ESPR
| $12K | ﹤0.01% |
+256
| New | +$12.3K |
|
2316
Entravision Communication
EVC
$1.1B
| $12K | ﹤0.01% |
4,271
-1,104
| -21% | -$4.32K |
|
2317
Primis Financial Corp
FRST
$404M
| $12K | ﹤0.01% |
+884
| New | +$13.3K |
|
2318
HighPeak Energy
HPK
$910M
| $12K | ﹤0.01% |
+1,204
| New | +$11.8K |
|
2319
Huntsman Corp
HUN
$1.77B
| $12K | ﹤0.01% |
628
-10,969
| -95% | -$235K |
|
2320
Hawkins
HWKN
$2.71B
| $12K | ﹤0.01% |
+600
| New | +$11.7K |
|
|
2321
iShares US Real Estate ETF
IYR
$4.57B
| $12K | ﹤0.01% |
158
-363,618
| -100% | -$28.6M |
|
2322
Jerash Holdings
JRSH
$63.5M
| $12K | ﹤0.01% |
1,826
-88
| -5% | -$571 |
|
2323
Lifecore Biomedical
LFCR
$190M
| $12K | ﹤0.01% |
+1,060
| New | +$14.6K |
|
2324
Littelfuse
LFUS
$11.6B
| $12K | ﹤0.01% |
71
-1,576
| -96% | -$281K |
|
2325
Newmont
NEM
$119B
| $12K | ﹤0.01% |
341
-6,099
| -95% | -$198K |
|
Similar funds
HFCIX
DWM
TFM
AC
IP
TCIM
FLSM
AFI
Tower Research Capital (TRC)'s Q4 2018 Portfolio in Review
As of Q4 2018, Tower Research Capital (TRC) held 4,841 positions worth $1.39B, up 1.7% from $1.36B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Tower Research Capital (TRC) deployed $245M of net new capital in Q4 2018, opening 999 new positions and adding to 1,367 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.
By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, down from 6.8% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $124M trimmed.
- Tower Research Capital (TRC)'s largest Q4 2018 buy was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.
- Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2018, an estimated $123M increase.
- Tower Research Capital (TRC)'s biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $124M.
- Tower Research Capital (TRC) fully exited State Street Energy Select Sector SPDR ETF in Q4 2018, selling an estimated $26.3M.
- Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.39B portfolio in Q4 2018.
- Tower Research Capital (TRC) opened 999 new positions and closed 908 in Q4 2018.
- Tower Research Capital (TRC)'s portfolio value rose 1.7% quarter-over-quarter to $1.39B.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.